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Abstract 
The objective of this pilot study was to determine the effect of dietary porcine plasma on 
circulating insulin-like growth factor 1 (IGF-1) concentrations in gestating sows and 
characteristics of their litters. Primiparous and multiparous sows were randomly allocated to two 
treatment groups of sows fed a basal diet or sows fed the basal diet plus 6 g of porcine plasma 
throughout gestation. On 4 periods during gestation and farrowing, blood was collected for IGF-
1 analysis. After farrowing, gestation length, number born, birth weight, and total litter weight 
were recorded. There were no three-way or two-way interactions between treatments, day of 
gestation, or parity for sow IGF-1 concentration (P>0.142). Treatment also did not affect 
(P=0.117) sow IGF-1 concentration. There were no treatment × parity or treatment effects on 
litter measures (P=0.170). Feeding porcine plasma at the low level employed in the study did not 
improve sow IGF-1 or litter measures. 
Keywords: Piglets, Fetal Growth, Porcine Plasma  
Introduction 
Selection for hyperprolific sows has increased litter size over the past two decades (Fix et al., 
2010) and simultaneously increased birth weight (BW) variation among litters (Milligan et al., 
2002). In litters of 11 piglets, 7% of piglets are classified as low birth weight, and as litter size 
increases up to 23% of piglets are classified as low birth weight (Fix et al., 2010). Piglets within 
litters that lie beneath the 10th percentile are classified as small for gestational age (SGA). Piglets 
that are classified as SGA experience survivability and low postnatal production efficiency 
problems that negatively impact the pork industry’s profitability and raise welfare issues 
(Wollmann, 1998; Mamelle et al., 2001; De Vos et al., 2014).  
 
The use of spray-dried porcine plasma has been utilized in various segments of early pig 
production. In the nursery phase, porcine plasma improves average daily gain (ADG) and gain to 
feed ratio (G:F) from d 0 to 14 post-weaning (Coffey and Cromwell, 1995; De Rodas et al., 
1995; Everts et al., 2001). The mode of action for plasma effects on growth is not known; 
however, De Rodas et al. (1995) found that piglets supplemented with plasma had greater plasma 
GH concentrations than piglets only fed a standard corn/soybean diet. Crenshaw et al. (2007) 
reported that plasma supplementation of lactating sows improved litter productivity during the 
lactation period. While there have not been many studies documenting the effects of porcine 
plasma on pig BW measures, there is interest in utilizing porcine plasma to increase the average 
piglet BW. Campbell et al. (2006) reported that 0.5% dietary spray-dried plasma increased 
farrowing rate; increased pigs born alive, and increased number of pigs weaned in a commercial 
herd with a history of porcine reproductive and respiratory syndrome virus. Therefore, the 
objectives of this study were to determine the effects porcine plasma supplementation to 
gestating sows on maternal circulating IGF-1 concentration and litter characteristics. 
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Literature Review 
Spray-dried plasma is a common feed supplement fed to pigs during various stages of early pig 
development. Coffey and Cromwell (1995) completed a series of experiments to first determine 
the appropriate level to supplement porcine plasma for nursery pigs, and compared feed ADG, 
G:F, and feed intake to pigs being supplemented with spray dried porcine plasma, dried skim 
milk, and a soybean meal. Authors observed that pigs that were supplemented with spray dried 
porcine plasma experienced greater ADG compared to pigs supplemented with soybean meal and 
dried skim milk. Additionally, pigs supplemented with spray dried porcine plasma had increased 
daily feed intake compared to pigs supplemented with soybean meal or dried skim milk. In one 
of their experiments pigs were fed in an experimental nursery that had fewer pigs and improved 
climate control compared to a conventional nursery. It is interesting that the impact of spray 
dried porcine plasma on ADG and feed intake was greater for pigs in a conventional nursery 
compared to the experimental nursery. This study illustrates that supplementation of spray dried 
plasma to nursery pigs effectively stimulates ADG through and increase in feed intake, but 
provides little insight into its impact on growth metabolites.  
 
Another study conducted by de Rodas et al. (1995) was aimed at determining the mode of action 
in which spray-dried porcine plasma improves ADG and feed intake in nursery pigs. Similar to 
the previous study discussed ADG and feed intake was increased for the first 14 days in the 
nursery. The plasma concentrations of insulin, IGF-1, growth hormone, and glucose were also 
evaluated. The plasma concentrations of IGF-1 and glucose were not affected by spray dried 
porcine plasma supplementation. Pigs that were supplemented with spray dried porcine plasma 
tended to have elevated levels of plasma growth hormone and decreased levels of insulin 
compared to pigs supplemented with soybean meal. In conjunction, these two studies indicate 
that spray dried porcine plasma can effectively improve growth performance nursery pigs 
through an increase in daily feed intake and partial stimulation of the somatotropic axis.  
 
Crenshaw et al. (2007) supplemented lactating sows with spray-dried porcine plasma to evaluate 
parameters involved in sow productivity and litter characteristics. Young sows (parity 1 and 2) 
that were supplemented with spray-dried porcine plasma had increased feed intake and decreased 
weight loss during lactation. In contrast mature sows (parity > 3) had decreased feed intake when 
they were supplemented with spray-dried porcine plasma. Interestingly, the weaning to estrus 
interval was improved in both young and mature sows. Litters from mature sows that were 
supplemented with spray-dried porcine plasma had an increased number of marketable pigs 
weaned and a greater average litter weights compared to sows that were not supplemented with 
spray dried porcine plasma.  
 
The current literature has evaluated the effects of porcine plasma on young pigs; however, there 
has been little research conducted regarding the effects of porcine plasma on fetal development 
of pigs.  Campbell et al., (2006) conducted a statistical process control analysis on 
supplementation of spray-dried plasma on gestating sows from a herd with a history of porcine 
reproductive and respiratory syndrome virus with porcine plasma at a rate of 0.5% of the diet and 
observed an increased farrowing rate, more pigs born alive, and increased number of pigs 
weaned. This report provides evidence that supplementation of porcine plasma can positively 
benefit swine production when supplemented during gestation, but does not define the mode of 
action in which porcine plasma elicits its response.    
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Materials and Methods 
Animals 
Experimental procedures were approved by the Institutional Animal Care and Use Committee at 
Kansas State University. Multiparous (previously farrowed one to three litters; n = 16) and 
primiparous (not previously farrowed; n = 10) were randomly allotted within parity to two 
treatment groups, basal diet (CON) and basal diet supplemented with porcine plasma (PP).  
Supplemented sows received 6 g top-dress of porcine plasma in their daily feed from d 6 of 
gestation (d 0=onset of estrus). Sows were fed once per day (08:00) 2.3 kg•animal-1•d-1of the 
gestation diet until d 100 ± 3 of gestation after which feed was increased to 3.2 kg•sow-1•d-1 
(Table 1). Beginning on d 106 ± 3 of gestation sows were fed 1.4 kg•animal-1•d-1of the standard 
KSU lactation diet twice daily until parturition. Approximately 24 to 36-hours postpartum, pigs 
were weighed individually and ear notched. Gestation length, number of pigs farrowed, and litter 
weight of live pigs were also recorded for each sow. 
 
Table 1. Composition (as fed basis) of diets fed to sows during gestation1 
Ingredient, % Gestation Lactation 
Corn 80.2 63.0 
Soybean meal 15.6 30.2 
Choice white grease 0.00 2.50 
Calcium 1.48 1.48 
Limestone 1.15 1.10 
Sodium chloride 0.50 0.50 
L-lysine hydrochloride 0.00 0.20 
DL-methionine 0.00 0.05 
L-threonine 0.03 0.08 
Trace mineral premix 0.15 0.15 
Sow add pack 0.50 0.50 
HiPhos 2700 0.02 0.02 
Vitamin premix 0.25 0.25 
1Sows were fed 2.3 kg•animal-1•d-1of the gestation diet until d 100 ± 3 of gestation after which 
feed was increased to 3.2 kg•animal-1•d-1. On d 106 ± 3 of gestation sows were fed 1.4 
kg•animal-1•d-1of the standard KSU lactation diet twice daily until parturition. The sows in the 
porcine plasma treatment had approximately 6 g of the diet replaced with porcine plasma. 
 
Blood and Body Weight Collection 
Pre-treatment blood and body weight were collected on d 5 of pregnancy to serve as a baseline 
for serum IGF-1 concentration. These measures were also collected on d 40, d 90, and within 36 
h after farrowing.  Blood was collected by jugular vein puncture with a BD Vacutainer® (BD, 
Franklin Lakes, NJ, USA) and serum was harvested as described (Tuck et al., 2009).  Briefly, 
blood samples were placed on ice immediately after collection, incubated for 30 min at room 
temperature to allow the blood to clot sufficiently, and serum was separated by centrifugation 
(1500 × g) for 25 min at 4ᵒC and was stored frozen (-80ᵒC) until analysis.  
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Serum Analysis 
Serum samples were assayed in triplicate using a human IGF-1 ELISA kit (ENZO Life Sciences, 
Farmingdale, NY). Optimal concentration of porcine serum used for analysis was determined by 
conducting a standard dilution curve and identifying sample concentrations that were near the 
middle of the linear portion of the dilution curve. The assay was validated for parallelism and 
recovery of added mass as described by Balaji et al. (2000). Parallelism was determined by using 
volumes of extract ranging from 25 µL to 100 µL. Volume corrected concentrations of IGF-1 
were regressed on the volume of extract and produced a regression line with a slope that had a 
95% confidence interval to include 1.0. Human IGF-1 standard was also recovered quantitatively 
when added to porcine IGF-1 samples. The limit for detection of this kit was 6 ng/mL. 
 
The assay measured total bound and unbound IGF-1 and Serum was mixed (1:5) in acidic 
ethanol (ethanol: 2N HCl, 7:1) and incubated 30 min to separate IGF-1 from IGF binding 
proteins. Binding proteins were precipitated by centrifugation (9,900 × g) for 5 min at room 
temperature.  Supernatant was removed and neutralized with an equal volume of neutralizing 
reagent. Samples were diluted 1:35 in assay buffer. Diluted samples (100 µL) were added to pre-
coated IGF-1 ELISA plates and incubated for 1 h. This and subsequent incubations were 
conducted on a shaker (500 rpm) at room temperature. The ELISA plate was rinsed 5 times with 
200 µL of wash buffer, and blotted on lint free paper towels after each rinse. After rinsing, 100 
µL of primary IGF-1 antibody was added to the wells in the ELISA plate and incubated for 2 h.  
Residual primary antibody on the plate was rinsed and blotted as described above. Blue 
conjugate (100 µL) was added to each well and incubated for 30 min. After incubation the 
ELISA plate was rinsed and blotted to remove residual blue conjugate. One hundred microliters 
of substrate solution was added and incubated 30 min, 100 µL of stop solution was added to each 
well, and sample absorbance measured at 450 nm using a BioTek EON spectrophotometer 
(BioTek, Winoski, VT). Concentrations were calculated based on absorbance values from a 
standard curve of known concentrations using Gen5 data analysis software (BioTek). 
 
Statistical Analysis 
The concentrations of IGF-1 in serum were analyzed as a randomized design with a 2 × 2 
factorial arrangement, utilizing repeated measures with sow as the experimental unit. The fixed 
effects included treatment, parity, day of blood collection, and all interactions. The random effect 
included sow within parity and day 5 serum IGF-1 concentration was used as a covariate. Day 
served as the repeated measure, with sow as the subject, and compound symmetry as the 
covariance structure. Analysis of body weight and backfat was conducted similar to the serum 
IGF-1 concentration data without the covariate. The second analysis was performed by first 
calculating the percent change from day-5 measures for serum IGF-1, bodyweight, and backfat. 
Data were analyzed as a randomized design with a 2 × 2 factorial arrangement and sow as 
experimental unit. Fixed effects were treatment, parity, and the treatment × parity interaction. 
 
Litter data were analyzed as a randomized design in a 2 × 2 factorial arrangement and sow as 
experimental unit. Fixed effects were treatment, parity, and treatment × parity. The random 
effect was sow within parity. All statistical analyses were performed using the MIXED 
Procedures of SAS 9.3 (Cary, NC). Pair-wise comparisons between the least square means of the 
factor levels, including planned interaction comparisons, were computed using the PDIFF option 
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of the LSMEANS statement. Differences were considered significant at α ≤ 0.05 and tendencies 
at α ≤ 0.10 
 
Results 
There were no three-way or two-way interactions for serum IGF-1 concentration (P > 0.142, 
Table 2, shown in the Appendix). Throughout the course of the study, sow total serum IGF-1 
concentration decreased (P < 0.001) for all sows. Parity influenced overall serum IGF-1 
concentration, with primiparous sows possessing greater (P < 0.001) serum IGF-1 than 
multiparous sows. Inclusion of the porcine plasma product in the diet did not affect (P = 0.117) 
serum IGF-1 levels. 
There were no parity × treatment × day, parity × treatment, or treatment × day interactions (P > 
0.156) for sow body weights.  There was a parity × day interaction (P < 0.001) for body weight. 
Primiparous sows weighed less than multiparous sows on all days (P < 0.001). All sows in the 
experiment increased (P < 0.001) in body weight over the course of the trial and multiparous 
sows weighed more (P < 0.001) than primiparous sows over the experiment. Inclusion of the 
commercial plasma product in the diet of the sows did not influence (P = 0.559) body weight.  . 
There was a parity × day interaction (P = 0.024) for sow backfat. Primiparous sows had more 
backfat than multiparous sows on day 40 post-estrus and at farrowing (P < 0.026), but both 
parities had similar backfat on the other days (P > 0.369). Other interactions did not (P > 0.513) 
affect backfat. Over the entire course of the study, treatment did not affect (P = 0.983) backfat, 
and backfat increased (P < 0.001) as day of gestation increased.    
Data were also analyzed as a percent change from the initiation of the trial (Table 3, shown in the 
Appendix). There were no parity × treatment interactions for changes in serum IGF-1 
concentrations at any of the sampling days (P > 0.144).  Multiparous sows experienced a greater 
decline in serum IGF-1 concentrations compared to primiparous sows on all sampling days (P < 
0.054).  Treatment did not affect the percent change of serum IGF-1 concentration on day-90 and 
at farrowing (P > 0.181); however, sows supplemented with porcine plasma tended to have less 
(P = 0.098) decrease in serum IGF-1 concentrations at day-40. There were no parity × treatment 
interactions for percent body weight change (P > 0.629). Primiparous sows gained more weight 
than multiparous sows at all weigh dates (P < 0.001). Body weight change for the first and 
second period of the trial was not different among treatments (P > 0.103). Sows supplemented 
with porcine plasma tended to gain less (P = 0.080) weight from the initiation of the trial to 
farrowing.  There were no parity × treatment interactions for change in backfat over the course of 
the study (P > 0.243).  Backfat increase tended to be greater (P = 0.061) for primiparous sows at 
day-40 than multiparous sows; however, backfat change was not different among parities at day-
90 or farrowing (P > 0.131).  Over the duration of the study, porcine plasma did not affect 
backfat measures (P > 0.248). 
Upon farrowing, gestation length and litter parameters were recorded (Table 4, shown in the 
Appendix). There were no parity × treatment interactions, parity effect, or treatment effects on 
gestation length and litter size (P > 0.113). There were no parity × treatment interactions or 
treatment effects for total litter weight and average piglet BW (P > 0.170); however, parity did 
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affect these two measures with multiparous sows having litters and individual piglets that 
weighed more than those from primiparous sows (P < 0.018). 
 
Discussion 
To date, a limited amount of research exists on the impact of porcine plasma on fetal 
development. One of the objectives of the current study was to increase maternal IGF-1 levels 
through the supplementation of dietary porcine plasma. While the utilization of plasma products 
to increase maternal IGF-1 concentrations have not been adequately explored, gestating sow 
IGF-1 levels have been manipulated through the use of porcine somatotropin administration. 
When supplemented during late gestation, porcine somatotropin increases maternal IGF-1 
concentration and fetal growth (Rehfeldt et al., 2004). The increased growth in response to 
porcine somatotropin and its associated IGF-1 response can also selectively increase birth weight 
of the smaller pig fetuses (Kuhn et al., 2004). In a poultry model, direct injection of IGF-1 into 
duck embryos increased weight (Wang et al., 2012). Therefore, there is a potential for elevated 
maternal IGF-1 concentration to affect fetal development. As illustrated in Figure 1 (Shown in 
the Appendix), serum IGF-1 concentrations were greatest at day-5 post estrus and dropped 66% 
to their lowest levels at day-90 post-estrus. At the time of farrowing, serum IGF-1 concentrations 
increased from day-90, but on average were still 23% less than serum IGF-1 concentrations on 
day-5 of pregnancy. Maternal hepatic IGF-1 status over the course of gestation has not 
adequately been characterized in swine.  Lee et al. (1993) reported that IGF-1 concentrations in 
the mammary glands follow a pattern similar to the serum concentrations in the current study, 
with levels reaching their lowest point at day-90 post estrus and increasing through farrowing. 
Therefore, these data reveal the gestating sow’s IGF-1 secretory pattern. 
 
The current study did not detect increased circulating maternal IGF-1 concentrations or effects 
on litter measurements due to porcine plasma supplementation. There was, however, a tendency 
for Porcine Plasma (PP) sows to have the smallest reduction in IGF-1 at day 40 of gestation, 
numerically maintain the greatest serum IGF-1 levels throughout gestation, and increase in IGF-
1 over day 5 levels at farrowing. The average litter weights would indicate that the product may 
increase piglet weight to a greater extent in the primiparous sows. Whether these differences 
would result in significant differences with greater numbers of sows will require additional 
experiments beyond this this pilot project. Another consideration is the amount of plasma 
product supplemented. Crenshaw et al. (2007) conducted a series of studies evaluating the 
impact of feeding plasma to lactating sows in a commercial setting. In the first 3 experiments, 
there were no effects of supplementing spray dried plasma on sow or litter performance when 
plasma was included at 0.25% of the diet. This level is similar to supplementation levels utilized 
in the current study. In their fourth study authors increased supplementation to 0.50% and 
observed increased feed disappearance, and more piglets that had a greater average body weight 
at weaning. They did not measure serum IGF-1, but when feed intake is increased, serum IGF-1 
and IGFBP3 levels are increased (Rehfeldt and Kuhn, 2006). Therefore, porcine plasma 
supplementation may be capable of augmenting the IGF axis through increases in feed intake. 
This mechanism was not possible in the present study because feed availability was restricted 
and did not differ between treatments. The data of Crenshaw et al. (2007) indicate a possible 
mechanism by which porcine plasma supplementation may increase circulating maternal IGF-1 
and enhance litter measurements. 
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Another interesting finding of the current study was the large differences in most measures 
between parities. Gatford et al. (2013) suggested that primiparous sows may be more susceptible 
to alterations in maternal nutrition due to the increased amount of nutrients needed for maternal 
growth, thus competing with fetal development. In the current study, the physiological 
limitations of primiparous sows to allocate nutrients to both growth and gestation are apparent. 
Multiparous sows had 21% greater total litter weights and 14% greater individual birth weights 
than primiparous sows. Primiparous sows gained more weight across the course of gestation and 
had 30% greater serum IGF-1 concentrations, which could indicate nutrients were more directed 
toward maternal growth. This hypothesis is supported by a trend for piglets from primiparous 
sows to exhibit a greater amount of brain sparing by having 10% greater brain to body weight 
ratio than piglets from multiparous sows (unpublished data). Therefore, sows of different ages 
may differ in their physiological response to treatments affecting fetal development. In light of 
these considerations, the primiparous sows’ response to the PP discussed above may indicate that 
PP is more effective in this class of sows. 
 
Conclusion 
The current pilot study demonstrated that supplementing a commercial plasma product during 
gestation did not affect piglet birth weight, which may be explained by the absence of an IGF-1 
response in maternal serum. Based on the physiological differences in parities of sows, it is 
important to identify the optimal supplementation strategy for primiparous and multiparous sows 
separately. Further research will be needed to determine an appropriate supplementation level of 
this porcine plasma product needed to elicit a beneficial response on the IGF axis, and 
potentially, result in improvements fetal development. 
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Table 2.  Circulating serum IGF-1 concentration, body weight, and backfat depth from primiparous and multiparous sows supplemented with or without porcine plasma 
during gestation   
 Primiparous Multiparous  P-value 
Treatment1 CON PP CON PP SEM Parity ×  Trt2 × Day Parity × Trt Parity × Day Trt × Day Parity Day Trt 
 n = 6 n = 4 n = 7 n = 9 - - - - - - - - 
Serum IGF-1, ng/mL             
D5 151.33 136.87 132.60 141.29 14.84 0.314 0.263 0.142 0.473 <0.001 <0.001 0.117 
D40 95.96 124.07 56.70 60.83 14.84        
D90 50.49 71.19 35.45 31.52 14.84        
Farrowing 102.59 157.86 82.09 84.69 14.84        
             
Body weight, kg             
D5 150.07 161.27 218.56 227.72 9.64 0.940 0.831 <0.001 0.156 <0.001 <0.001 0.559 
D40 169.02 175.82 218.06 223.79 9.64        
D90 201.75 204.30 247.99 248.17 9.64        
Farrowing 220.97 223.85 271.54 267.38 9.64        
             
Backfat, mm             
D5 14.08 13.75 13.00 13.78 1.05 0.513 0.999 0.024 0.666 0.123 <0.001 0.983 
D40 15.83 16.25 13.43 13.44 1.05        
D90 16.33 15.50 15.14 14.78 1.05        
Farrowing 18.42 19.25 16.57 16.22 1.05        
1CON = sows fed the control dietary regimen only. PP = sows fed the control dietary regimen plus 6 g of porcine plasma daily.  Sows were fed 2.3  kg•animal-1•d-1of 
the gestation diet until d 100 ± 3 of gestation after which feed was increased to 3.2  kg•animal-1•d-1 (Table 1). On d 106 ± 3 of gestation sows were fed 1.4 kg•animal-1•d-1of 
the standard KSU lactation diet twice daily until parturition. Supplementation of porcine plasma was initiated 6 days post-estrus. 
2Trt = treatment main effect. 
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Table 3. Percent change in sow serum IGF-1 concentrations, body weight, and backfat from primiparous and multiparous sows 
supplemented with or without porcine plasma during gestation 
 Treatment1   
 Primiparous Multiparous  P-value 
 CON PP CON PP SEM Parity × Trt2 Parity Trt 
D5 - D403         
Serum IGF-1, ng/mL -35.26 -6.67 -57.80 -52.26 12.07 0.256 0.002 0.098 
Body weight, kg 12.72 9.09 0.24 -1.40 2.47 0.629 <0.001 0.207 
Backfat, mm 13.14 18.17 5.93 -0.02 8.39 0.365 0.061 0.850 
D5 - D904         
Serum IGF-1, ng/mL -64.06 -45.42 -74.68 -75.16 8.03 0.160 0.006 0.181 
Body weight, kg 34.73 26.87 14.48 9.51 4.59 0.704 <0.001 0.103 
Backfat, mm 18.79 13.41 18.47 7.74 8.29 0.697 0.664 0.248 
D5 – farrowing5         
Serum IGF-1, ng/mL -27.59 17.47 -36.05 -40.00 19.77 0.144 0.054 0.217 
Body weight, kg 47.51 39.00 25.49 18.07 5.30 0.900 <0.001 0.080 
Backfat, mm 32.91 40.97 29.95 18.72 9.81 0.243 0.131 0.845 
1CON = sows fed the control dietary regimen only. PP = sows fed the control dietary regimen plus 6 g of porcine plasma daily.  
Sows were fed 2.3  kg•animal-1•d-1of the gestation diet until d 100 ± 3 of gestation after which feed was increased to 3.2  kg•animal-
1•d-1 (Table 1). On d 106 ± 3 of gestation sows were fed 1.4 kg•animal-1•d-1of the standard KSU lactation diet twice daily until 
parturition. Supplementation of porcine plasma was initiated 6 days post-estrus. 
2Trt = treatment main effect. 
3Data represents the values from day-40 post-estrus divided by the values from day-5 post-estrus and multiplied by 100. 
4Data represents the values from day-90 post-estrus divided by the values from day-5 post-estrus and multiplied by 100. 
5Data represents the values from farrowing divided by the values from day-5 post-estrus and multiplied by 100. 
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Table 4. Gestation length, litter size, average piglet weight, and total litter weight from primiparous and multiparous sows 
supplemented with or without porcine plasma during gestation 
 Primiparous Multiparous  P-value 
Treatment1 CON PP CON PP SEM Parity*Trt2 Parity Trt 
Gestation Length, days 114.33 115.00 115.14 115.28 0.50 0.762 0.113 0.205 
Litter Size 12.17 11.00 13.42 11.56 1.40 0.761 0.437 0.199 
Average Piglet weight, g 1,259.53 1,426.28 1,519.87 1,585.59 100.10 0.544 0.018 0.170 
Total litter weight, kg 15.22 14.79 20.14 17.87 5.35 0.374 <0.001 0.196 
1CON = sows fed the control dietary regimen only. PP = sows fed the control dietary regimen plus 6 g of porcine plasma daily.  
Sows were fed 2.3 kg•animal-1•d-1of the gestation diet until d 100 ± 3 of gestation after which feed was increased to 3.2  kg•animal-
1•d-1 (Table 1). On d 106 ± 3 of gestation sows were fed 1.4 kg•animal-1•d-1of the standard KSU lactation diet twice daily until 
parturition. Supplementation of porcine plasma was initiated 6 days post-estrus. 
2Trt = treatment main effect. 
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Figure 1.  Circulating serum IGF-1 concentration of primiparous and multiparous sows supplemented with or without porcine plasma 
during gestation. CON = sows fed the control dietary regimen only. PP = sows fed the control dietary regimen plus 6 g of porcine 
plasma daily.  Sows were fed 2.3 kg•animal-1•d-1of the gestation diet until d 100 ± 3 of gestation after which feed was increased to 3.2  
kg•animal-1•d-1 (Table 1). On d 106 ± 3 of gestation sows were fed 1.4 kg•animal-1•d-1of the standard KSU lactation diet twice daily 
until parturition. Supplementation of porcine plasma was initiated 6 days post-estrus. 
 
Trt   P  = 0.117 
Day   P <  0.001 
Parity    P <  0.001 
Interactions P > 0.142 
SEM  14.84 
